Lower expression of METTL14 was significantly associated with poorer prognosis in KIRC patients (Figures 1E, 4I), which showed that METTL14 acts as a tumor suppressor gene in the tumorigenesis of KIRC. The gene discussed is METTL14; the disease is neoplasm.